Johnson & Johnson gets FDA warning on marketing

[DainBramaged]

The article starts out discussing the marketing of Johnson & Johnson's DePuy Orthopaedics Inc. division but the INTERESTNG part is in the bottom half of the article:

On Monday, Johnson & Johnson issued its ninth product recall in a year, this one covering millions of 1 Day Acuvue TruEye contact lenses sold in Japan and two dozen other countries in Asia and Europe. The recall followed complaints from customers in Japan of an unusual stinging or pain when inserting the lenses. Johnson & Johnson's Vision Care Inc. business blamed the failure of manufacturing equipment that rinses off substances used in producing the lenses.


Johnson & Johnson already is under scrutiny by FDA officials, Congress and federal prosecutors over eight previous U.S. recalls of nonprescription medicines since last September. Those included millions of bottles of Tylenol, other pain relievers and cold medicines for children and adults.


The recalls have involved problems ranging from bacterial contamination and a nauseating smell on containers to drugs that may have the wrong amount of active ingredient and liquid medicines that may contain tiny metal shavings.

http://www.dailyrecord.com/article/20100825/COMMUNITIES/308250007/1203/COMMUNITIES/Johnson-&-Johnson-gets-FDA-warning-on-marketing-

http://www.fda.gov/downloads/Safety/Recalls/UCM197769.pdf (J&J product recalls)

April 30, 2010:

Products: 40 products including liquid infant and children's pain relievers, Tylenol, and Motrin and allergy medications Zyrtec and Benadryl.

Problem: Manufacturing deficiencies that may have affected the quality, purity or potency of the medicines.

January 15, 2010:

Products: 53 million bottles of over-the-counter products including Tylenol, Motrin and Rolaids, Benadryl and St. Joseph's Aspirin, involving lots in the Americas, the United Arab Emirates and Fiji.

Problem: Unusual moldy, musty or mildew-like odor

December 2009:

Product: Expands November recall of Tylenol Arthritis Pain Caplets

Problem: Consumer reports of unusual moldy odor with the 100-count bottles

November 2009:

Product: Five lots of Tylenol Arthritis Pain Caplets

Problem: Reports of an unusual musty or mildew-like odor that was associated with nausea, stomach pain, vomiting and diarrhea

September 2009:

Products: Some lots of infants' and children's Tylenol

Problem: Possible bacterial contamination

November 2008:

Product: About 12,000 bottles of Mylicon over-the-counter infant anti-gas drops in the dye-free variety. (Mylicon sells the product in a 50-50 joint venture with Merck & Co (MRK.N))

Problem: Bottles may have contained metal fragments.

[DJ13]

1. Too many corners cut in an effort to increase "shareholder value"

Its the same problem at the root of Toyota's recent problems.

We really need to eliminate the tying of executive bonuses to stock performance ..... before it kills again.